Jamie M Jacobs1,2, Kelly M Shaffer3,4, Ryan D Nipp5, Joel N Fishbein6, James MacDonald6, Areej El-Jawahri5, William F Pirl7, Vicki A Jackson8, Elyse R Park6,3, Jennifer S Temel5, Joseph A Greer6,3. 1. Center for Psychiatric Oncology and Behavioral Sciences, Massachusetts General Hospital Cancer Center & Harvard Medical School, 55 Fruit Street, Yawkey Center, Suite 10B, Boston, MA, 02114, USA. jjacobs@mgh.harvard.edu. 2. Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. jjacobs@mgh.harvard.edu. 3. Department of Psychiatry, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. 4. Department of Psychology, University of Miami, Coral Gables, FL, USA. 5. Department of Medicine, Division of Hematology & Oncology, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA. 6. Center for Psychiatric Oncology and Behavioral Sciences, Massachusetts General Hospital Cancer Center & Harvard Medical School, 55 Fruit Street, Yawkey Center, Suite 10B, Boston, MA, 02114, USA. 7. Sylvester Cancer Center, University of Miami Miller School of Medicine, Miami, FL, USA. 8. Department of Medicine, Division of Palliative Care, Massachusetts General Hospital & Harvard Medical School, Boston, MA, USA.
Abstract
BACKGROUND:Individuals with advanced, incurable cancer often experience high physical and psychological symptom burden. Family and friend caregivers are at risk for emotional distress. PURPOSE: The aim of the study is to investigate the interrelationship of distress in patient-caregiver dyads at the time of newly diagnosed incurable cancer. METHODS: From May 2011 to July 2015, within 8 weeks of diagnosis of advanced lung or noncolorectal gastrointestinal cancer, 350 patients and 275 family caregivers were enrolled in a randomized controlled trial of early palliative care. Actor-partner interdependence modeling was used to examine relationships between dyad's self-reported anxiety and depressive symptoms on the Hospital Anxiety and Depression Scale at baseline. RESULTS: Comparing patients with caregivers, patients reported more depressive symptoms (M diff = .84; t[274] = 3.17, p = .002, d = .22) and caregivers reported more anxiety symptoms (M diff =1.62, t[274] = 4.91, p < .001, d = .39). Dyads' anxiety symptoms were positively associated, as were depressive symptoms (rs = .21, ps ≤ .001). Actor-partner interdependence modeling showed that patients' anxiety symptoms were positively associated with their own depressive symptoms, with an equal effect for caregivers (actor effect βs = 0.52, ps < .001). Patients' own anxiety was concurrently positively associated with their caregivers' depressive symptoms, with an equal effect for caregivers to patients (partner effect βs=0.08, ps=.008). CONCLUSIONS: In the context of newly diagnosed incurable cancer, caregivers experience more pronounced anxiety, while patients report greater depressive symptoms. Findings indicate that anxiety and depressive symptoms are interrelated among dyads facing newly diagnosed incurable disease. Results emphasize the importance of addressing distress in both patients and caregivers. Future research should discern when dyadic versus individual psychosocial interventions would be optimal. TRIAL REGISTRATION NUMBER: The trial was registered with the ClinicalTrials.gov database (NCT02349412) https://clinicaltrials.gov/ct2/show/NCT02349412 .
RCT Entities:
BACKGROUND: Individuals with advanced, incurable cancer often experience high physical and psychological symptom burden. Family and friend caregivers are at risk for emotional distress. PURPOSE: The aim of the study is to investigate the interrelationship of distress in patient-caregiver dyads at the time of newly diagnosed incurable cancer. METHODS: From May 2011 to July 2015, within 8 weeks of diagnosis of advanced lung or noncolorectal gastrointestinal cancer, 350 patients and 275 family caregivers were enrolled in a randomized controlled trial of early palliative care. Actor-partner interdependence modeling was used to examine relationships between dyad's self-reported anxiety and depressive symptoms on the Hospital Anxiety and Depression Scale at baseline. RESULTS: Comparing patients with caregivers, patients reported more depressive symptoms (M diff = .84; t[274] = 3.17, p = .002, d = .22) and caregivers reported more anxiety symptoms (M diff =1.62, t[274] = 4.91, p < .001, d = .39). Dyads' anxiety symptoms were positively associated, as were depressive symptoms (rs = .21, ps ≤ .001). Actor-partner interdependence modeling showed that patients' anxiety symptoms were positively associated with their own depressive symptoms, with an equal effect for caregivers (actor effect βs = 0.52, ps < .001). Patients' own anxiety was concurrently positively associated with their caregivers' depressive symptoms, with an equal effect for caregivers to patients (partner effect βs=0.08, ps=.008). CONCLUSIONS: In the context of newly diagnosed incurable cancer, caregivers experience more pronounced anxiety, while patients report greater depressive symptoms. Findings indicate that anxiety and depressive symptoms are interrelated among dyads facing newly diagnosed incurable disease. Results emphasize the importance of addressing distress in both patients and caregivers. Future research should discern when dyadic versus individual psychosocial interventions would be optimal. TRIAL REGISTRATIONNUMBER: The trial was registered with the ClinicalTrials.gov database (NCT02349412) https://clinicaltrials.gov/ct2/show/NCT02349412 .
Authors: Jamie M Stagl; Suzanne C Lechner; Charles S Carver; Laura C Bouchard; Lisa M Gudenkauf; Devika R Jutagir; Alain Diaz; Qilu Yu; Bonnie B Blomberg; Gail Ironson; Stefan Glück; Michael H Antoni Journal: Breast Cancer Res Treat Date: 2015-10-30 Impact factor: 4.872
Authors: C Nijboer; R Tempelaar; R Sanderman; M Triemstra; R J Spruijt; G A van den Bos Journal: Psychooncology Date: 1998 Jan-Feb Impact factor: 3.894
Authors: Kelly Chinh; Ekin Secinti; Shelley A Johns; Adam T Hirsh; Kathy D Miller; Bryan Schneider; Anna Maria Storniolo; Lida Mina; Erin V Newton; Victoria L Champion; Catherine E Mosher Journal: Oncol Nurs Forum Date: 2020-11-01 Impact factor: 2.172
Authors: Joseph A Greer; Allison J Applebaum; Juliet C Jacobsen; Jennifer S Temel; Vicki A Jackson Journal: J Clin Oncol Date: 2020-02-05 Impact factor: 44.544
Authors: Colleen K McIlvennan; Daniel D Matlock; Larry A Allen; Jocelyn S Thompson; Krista W Ranby; Timothy S Sannes Journal: Circ Cardiovasc Qual Outcomes Date: 2020-03-09
Authors: Emma Meyers; Ann Lin; Ethan Lester; Kelly Shaffer; Jonathan Rosand; Ana-Maria Vranceanu Journal: Gen Hosp Psychiatry Date: 2019-12-20 Impact factor: 3.238
Authors: Heather M Derry; Andrew S Epstein; Wendy G Lichtenthal; Holly G Prigerson Journal: Expert Rev Anticancer Ther Date: 2019-08-10 Impact factor: 4.512
Authors: Maija Reblin; Amy K Otto; Dana Ketcher; Susan T Vadaparampil; Lee Ellington; Richard E Heyman Journal: Psychooncology Date: 2020-06-08 Impact factor: 3.894